TC
PFE icon

Tairen Capital’s Pfizer PFE Stock Holding History

Tairen Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-130,000
Closed -$3.29M – 97
2025
Q1 		$3.29M Hold
130,000
– – 0.22% 73
2024
Q4 		$3.45M Hold
130,000
– – 0.51% 38
2024
Q3 		$3.68M Buy
+130,000
New +$3.79M 0.13% 30
2022
Q2 		– Sell
-11,042
Closed -$572K – 36
2022
Q1 		$572K Buy
+11,042
New +$573K 0.07% 35

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Tairen Capital's PFE Position: Q2 2025 in Review

Tairen Capital sold out of Pfizer (PFE) in Q2 2025, closing a stake of 130,000 shares — an estimated $3.29M sold.

Tairen Capital first reported a position in PFE in Q1 2022 and held it in 4 quarters. The position peaked at $3.68M in Q3 2024. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Tairen Capital reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Tairen Capital sold 130,000 Pfizer shares in Q2 2025, an estimated $3.29M.
  • Tairen Capital first reported a position in Pfizer in Q1 2022 and held it in 4 quarters.
  • Tairen Capital's Pfizer position peaked at $3.68M in Q3 2024.
  • 2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Tairen Capital's 13F filing for Q2 2025, filed 12 Aug 2025.